Ionis Pharmaceuticals, Inc. (IONS)

NASDAQ: IONS · Real-Time Price · USD

75.27

+0.51 (0.68%)

At close: May 1, 2026, 4:00 PM EDT

75.30

+0.03 (0.04%)

After-hours: May 1, 2026, 7:45 PM EDT

Ionis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	173.38	372.26	242.08	399.27	276.47	869.19
Short-Term Investments	1,746	2,305	2,056	1,932	1,710	1,246
Cash & Short-Term Investments	1,919	2,677	2,298	2,331	1,987	2,115
Cash Growth	-10.54%	16.53%	-1.44%	17.33%	-6.06%	11.76%
Accounts Receivable	73.68	66.06	92.19	97.78	25.54	61.9
Inventory	5.56	10.05	12.51	7.44	22.03	24.81
Other Current Assets	306.08	237.09	217.93	205.43	168.25	143.37
Total Current Assets	2,937	2,991	2,620	2,642	2,203	2,345
Net Property, Plant & Equipment	377.47	361.6	256.11	242.94	255.84	196.04
Other Long-Term Assets	768.07	171.6	127.28	105.28	75.34	70.6
Total Assets	3,450	3,524	3,004	2,990	2,534	2,612
Accounts Payable	26.03	28.08	42.96	26.03	17.92	11.9
Accrued Expenses	162.6	222.33	178.05	215.62	189.28	127.37
Current Portion of Long-Term Debt	432.5	431.95	-	44.33	-	-
Unearned Revenue	69.2	73.76	78.99	151.13	90.58	97.71
Other Current Liabilities	26.26	25.45	9.31	10.98	13.78	3.56
Total Current Liabilities	716.59	781.57	309.32	448.09	311.56	240.55
Long-Term Debt	1,349	1,347	1,245	1,230	1,183	1,228
Long-Term Leases	259.22	262.38	161.81	170.88	178.94	19.43
Other Long-Term Liabilities	633.51	643.35	698.72	754.92	287.77	351.88
Total Long-Term Liabilities	2,242	2,253	2,106	2,155	1,649	1,599
Total Liabilities	2,959	3,035	2,415	2,603	1,961	1,840
Common Stock	0.17	0.16	0.16	0	0	0.14
Additional Paid-in Capital	3,246	3,145	2,869	2,215	2,060	1,964
Accumulated Other Comprehensive Income	-31.02	-25.28	-30.81	-32.65	-57.48	-32.67
Retained Earnings	-2,724	-2,631	-2,250	-1,796	-1,430	-1,160
Total Common Shareholders' Equity	491.41	489.09	588.35	386.54	572.75	771.74
Shareholders' Equity	491.41	489.09	588.35	386.69	572.89	771.74
Total Liabilities & Equity	3,450	3,524	3,004	2,990	2,534	2,612
Total Debt	2,041	2,042	1,407	1,445	1,362	1,248
Net Cash (Debt)	-121.84	635.66	890.37	886.49	625.21	867.45
Net Cash Growth	-	-28.61%	0.44%	41.79%	-27.93%	-8.95%
Net Cash Per Share	-0.73	3.97	5.96	6.19	4.41	6.15
Book Value	491.41	489.09	588.35	386.54	572.75	771.74
Book Value Per Share	2.94	3.06	3.94	2.70	4.04	5.47
Tangible Book Value	491.41	489.09	588.35	386.54	572.75	771.74
Tangible Book Value Per Share	2.94	3.06	3.94	2.70	4.04	5.47

Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q